Eryngium
diabetes
dyslipidemia
medicinal plant
metabolic syndrome
Journal
Frontiers in nutrition
ISSN: 2296-861X
Titre abrégé: Front Nutr
Pays: Switzerland
ID NLM: 101642264
Informations de publication
Date de publication:
2022
2022
Historique:
received:
17
02
2022
accepted:
28
04
2022
entrez:
7
6
2022
pubmed:
8
6
2022
medline:
8
6
2022
Statut:
epublish
Résumé
Medicinal plants possess natural compounds that can be used as an alternative for synthetic medicines that may cause long-term side effects on patients such as neurocognitive effects, muscular and hepatic toxicity. Metabolic Syndrome is associated with increased risk of several diseases such as diabetes, cardiovascular disease, dyslipidemia, and hypertension thus, becoming the greatest challenge as a growing public health concern worldwide. Latin-American countries possess a wide diversity of medicinal plants that have been used to treat different health conditions since pre-Hispanic times.
Identifiants
pubmed: 35669072
doi: 10.3389/fnut.2022.878306
pmc: PMC9165641
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
878306Informations de copyright
Copyright © 2022 Pérez-Muñoz, Antunes-Ricardo, Martínez-Ávila and Guajardo-Flores.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Nutr Metab (Lond). 2020 Aug 3;17:61
pubmed: 32774439
Front Genet. 2021 Nov 22;12:769699
pubmed: 34880906
Oxid Med Cell Longev. 2019 May 5;2019:8267234
pubmed: 31191805
CJC Open. 2020 Sep 28;3(2):195-197
pubmed: 33644733
Ann N Y Acad Sci. 2018 Jan;1411(1):21-35
pubmed: 28868790
J Lipid Res. 2018 Jul;59(7):1103-1113
pubmed: 29728459
J Atheroscler Thromb. 2018 Sep 1;25(9):771-782
pubmed: 29998913
Exp Clin Endocrinol Diabetes. 2019 Dec;127(S 01):S1-S7
pubmed: 31860923
Curr Diabetes Rev. 2018;14(5):427-433
pubmed: 28677496
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):1217-1224
pubmed: 32682310
Biomed Res Int. 2019 Mar 12;2019:3692605
pubmed: 30993111
J Ethnopharmacol. 2021 Oct 28;279:114339
pubmed: 34166734
Plants (Basel). 2021 Sep 29;10(10):
pubmed: 34685869
Diabetes Metab Syndr Obes. 2020 Oct 09;13:3611-3616
pubmed: 33116712
Dtsch Med Wochenschr. 2021 Jan;146(2):85-91
pubmed: 33465804
Molecules. 2022 Jan 30;27(3):
pubmed: 35164215
Int J Cosmet Sci. 2020 Apr;42(2):127-135
pubmed: 31799709
Diabetol Metab Syndr. 2021 Mar 2;13(1):25
pubmed: 33653388
Evid Based Complement Alternat Med. 2017;2017:3176232
pubmed: 29387127
Hormones (Athens). 2018 Mar;17(1):61-67
pubmed: 29858856
Biochem Res Int. 2012;2012:603501
pubmed: 22162811
J Med Food. 2020 Aug;23(8):827-833
pubmed: 31829771
Front Pharmacol. 2021 Oct 07;12:752926
pubmed: 34690784
Cardiol Res Pract. 2014;2014:943162
pubmed: 24711954
Antioxidants (Basel). 2019 Mar 26;8(3):
pubmed: 30917540
Front Endocrinol (Lausanne). 2019 Oct 15;10:702
pubmed: 31681173
Front Endocrinol (Lausanne). 2019 Jan 10;9:806
pubmed: 30687238
Front Chem. 2020 Nov 26;8:558641
pubmed: 33335883
J Ethnobiol Ethnomed. 2021 Aug 3;17(1):48
pubmed: 34344391
Circ Res. 2019 Jun 7;124(12):e121-e122
pubmed: 31170055
J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2005-e2014
pubmed: 33524107
Physiology (Bethesda). 2019 Mar 1;34(2):134-149
pubmed: 30724128
Res Pharm Sci. 2021 Mar 05;16(2):193-202
pubmed: 34084206
Front Cardiovasc Med. 2020 Feb 18;7:12
pubmed: 32133373
Am J Physiol Cell Physiol. 2019 Apr 1;316(4):C559-C566
pubmed: 30789754
J Clin Med. 2019 Sep 04;8(9):
pubmed: 31487953
Curr Diab Rep. 2018 Oct 17;18(12):127
pubmed: 30328521
J Lipid Atheroscler. 2019 Sep;8(2):183-191
pubmed: 32821708
Front Pharmacol. 2021 Mar 12;11:554961
pubmed: 33776749
Plants (Basel). 2022 Apr 05;11(7):
pubmed: 35406972
Front Pharmacol. 2020 Mar 04;11:148
pubmed: 32194403
Molecules. 2021 Sep 09;26(18):
pubmed: 34576959
Int J Mol Sci. 2021 Mar 05;22(5):
pubmed: 33807969